Aminohippurate sodium

氨基马尿酸钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAminohippurate sodium
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDiagnostic agentsWeight LossDiabetes Complications +[10
Global Approved IndicationsDiagnostic agents
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1944/12/30
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiagnostic agentsWeight LossDiabetes Complications +[10
Inactive IndicationsN/A

Other Information

ATC CodeV04CH30